Fangping Xu
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Endocrine and Autonomic Systems top 10%
- Regulation of Appetite and Obesity
Papers in
- Oncology 12
- HER2/EGFR in Cancer Research 9
- Cancer Treatment and Pharmacology 2
-
- Epigenetics and DNA Methylation 3
- Cancer-related gene regulation 2
- Co-authors
- Jiandong Luo (3 shared papers)Minsheng Chen (2 shared papers)Yanzhen Wang (2 shared papers)Yan‐Hui Liu (17 shared papers)Yi Quan (1 shared paper)Alex F. Chen (1 shared paper)Xin-lan Luo (17 shared papers)Donglan Luo (14 shared papers)
- Journals
- American Journal of Clinical Pathology (3 papers)Diagnostic Pathology (2 papers)Journal of Cancer (2 papers)Breast Cancer Research and Treatment (2 papers)British Journal of Radiology (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Fangping Xu
49 papers receiving 848 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 177
- Endocrine and Autonomic Systems 71
- Oncology 183
- Cardiology and Cardiovascular Medicine 98
- Pathology and Forensic Medicine 75
Countries citing papers authored by Fangping Xu
This map shows the geographic impact of Fangping Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangping Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangping Xu more than expected).
Fields of papers citing papers by Fangping Xu
This network shows the impact of papers produced by Fangping Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangping Xu. The network helps show where Fangping Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Fangping Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 197 | |
| 2 | 2015 | 99 | |
| 3 | 2013 | 48 | |
| 4 | 2006 | 47 | |
| 5 | 2019 | 37 | |
| 6 | 2004 | 36 | |
| 7 | 2006 | 34 | |
| 8 | 2010 | 33 | |
| 9 | 2022 | 27 | |
| 10 | 2021 | 27 | |
| 11 | 2017 | 25 | |
| 12 | 2017 | 21 | |
| 13 | 2012 | 20 | |
| 14 | 2017 | 18 | |
| 15 | 2009 | 18 | |
| 16 | 2006 | 16 | |
| 17 | 2021 | 11 | |
| 18 | 2022 | 10 | |
| 19 | [Association of HER2 protein expression with clinicopathologic features and prognosis in Chinese patients with gastric carcinoma]. | 2011 | 10 |
| 20 | 2021 | 9 |
About Fangping Xu
Fangping Xu is a scholar working on Oncology, Molecular Biology, Cancer Research, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine, having authored 53 papers that have together received 863 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Breast Cancer Treatment Studies (6 papers), Epigenetics and DNA Methylation (3 papers), Fatty Acid Research and Health (2 papers), Cancer Treatment and Pharmacology (2 papers), Cardiac tumors and thrombi (2 papers), Nutritional Studies and Diet (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Cancer Research (177 citations), Endocrine and Autonomic Systems (71 citations), Oncology (183 citations), Cardiology and Cardiovascular Medicine (98 citations) and Pathology and Forensic Medicine (75 citations). Fangping Xu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Jiandong Luo, Minsheng Chen, Yanzhen Wang, Yan‐Hui Liu, Yi Quan, Alex F. Chen, Xin-lan Luo, Donglan Luo, Jie Xu and Jiong Bi. Their work appears in journals such as American Journal of Clinical Pathology, Diagnostic Pathology, Journal of Cancer, Breast Cancer Research and Treatment and British Journal of Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.